Resources

Resources

Results

No results found. Please try using different filter option(s).

In the media

18 Jan 2025

Drugmakers tap AI to develop new treatments

NHK

In the media

9 Jan 2025

Pourquoi les derniers cas de maladie du sommeil seront les plus difficiles à éliminer ?

Nature

Scientific articles

10 Jan 2025

Congenital Chagas disease: A cohort study to assess molecular diagnostic methods at the Chagas disease national reference center of Argentina

PLOS Neglected Tropical Diseases

In the media

9 Jan 2025

Why the last cases of sleeping sickness will be the hardest to eliminate

Nature

In the media

6 Jan 2025

We asked global thinkers how to improve life on earth in 2025. Here are their wishes

NPR

In the media

4 Jan 2025

A promising fight against a silent killer

Global Health NOW

Scientific articles

20 Dec 2024

Challenges of sharing individual participant data for secondary research on neglected tropical diseases: the experience of Drugs for Neglected Diseases initiative and a call for action

BMJ Open

News

19 Dec 2024

Message on the passing of Dr Yves Champey from DNDi Executive Director Dr Luis Pizarro

News

17 Dec 2024

DNDi 2024 in Review

In the media

13 Dec 2024

“顧みられない熱帯病” 治療薬開発でAIに期待研究開発機関

NHK

Stories

13 Dec 2024

Drug discovery explained: What is high-throughput screening?

Publications

12 Dec 2024

LEAP Newsletter

In the media

12 Dec 2024

エーザイ、認知症治療薬の次は「まん延する顧みられない熱帯病」

Nikkeii Business

In the media

11 Dec 2024

«Pour convaincre le capital privé d’investir en faveur de la nature, il faut lui offrir des options de sortie»

Agefi

In the media

9 Dec 2024

Interview de Laurent Fraisse sur les besoins pédiatriques liés aux maladies tropicales négligées

RFI Priorité Santé

In the media

6 Dec 2024

Afrique de l’Est: la bataille contre la maladie de leishmaniose [2/2]

RFI

Scientific Articles

Loading...

Publications

Loading...

Videos

Loading...

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

Get in touch

Support us

Work with us